You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
ST中基(000972.SZ)擬設立四家全資子公司 增加醫藥類業務
格隆匯 11-13 17:11

格隆匯11月13日丨ST中基(000972.SZ)公佈,為開拓新的盈利增長點,達成經營業務轉型升級目的,增加盈利能力,更好保護股東權益尤其是中小投資者合法權益,實現持續穩定健康發展,公司投資設立四家全資子公司:1、上海中基藥業有限公司(“上海中基藥業”,暫定名,最終以工商核准為準);2、上海中基醫藥科技有限公司(“上海中基醫藥”,暫定名,最終以工商核准為準);3、新疆中基藥業有限公司(“新疆中基藥業”,暫定名,最終以工商核准為準);4、新疆中基醫藥科技有限公司(“新疆中基醫藥”,暫定名,最終以工商核准為準)。上述擬投資設立的四家全資子公司,註冊資本均為1000萬元。

設立上海中基醫藥、新疆中基醫藥的目的:在上海和新疆進行醫藥產業投資,開展相關產業的研發及生產,達成主營業務的轉型升級目的,增強盈利能力,更好保護股東權益尤其是中小投資者合法權益,實現持續穩定健康發展。

設立上海中基藥業、新疆中基藥業的目的:在上海及新疆建立藥品的銷售網絡,擴大公司醫藥銷售能力,實現產業投資可持續性。

公司將增加醫藥類業務,實現公司業務的轉型升級,提升公司的綜合實力,實現公司長期、持續、穩定的發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account